Sissel v. United States Department of Health & Human Services

Travel Vaccine Global Market Report 2022: Stringent Advisories and Regulations by Health Authorities to Aid Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Other Travel, Pharmaceutical, Health, Travel, Sissel v. United States Department of Health & Human Services, COVID-19, Growth, Rotavirus, Typhoid fever, International Certificate of Vaccination or Prophylaxis, Human services, National Health Service, Health, Vaccine, Infection, Tetanus, Hepatitis B, Antibody, Hepatitis A, Fever Dream, Shingles, Tourism, Yellow fever, Travel, Cholera, Meningitis, Diphtheria, Disease, Spiritualism, Vaccination, Rubella, Mumps, Measles, Polio, Composition, Chickenpox, NHS, DPT, Rabies

The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027.

Key Points: 
  • The global travel vaccine market is anticipated to grow at a steady rate in the forecast period, 2023-2027.
  • The market growth can be attributed to the rising incidences of flu and rapid growth in the travel and tourism sector.
  • Travel vaccines, also known as travel immunizations, are vaccine shots that protect travelers from serious illnesses.
  • Increasing regulations for safe traveling are supporting the normalization of travel vaccines among travelers, which is expected to boost the market growth.

The FDA Misled the Public About Ivermectin and Should Be Accountable in Court, Argues the Association of American Physicians and Surgeons (AAPS)

Retrieved on: 
Friday, September 30, 2022
Department, Prevalence, FDA, Food, COVID-19, Organization, HHS, Â, Thought, Association of American Physicians and Surgeons, Physician, Human services, AAPS, Sissel v. United States Department of Health & Human Services, Motion, Association, Medicine, GLOBE, Health, Food and Drug Administration, Ivermectin, Pharmaceutical industry, Surgeon

Not only is off-label prescribing fully proper, legal, and commonplace, but it is also absolutely necessary in order to give effective care to patients.

Key Points: 
  • Not only is off-label prescribing fully proper, legal, and commonplace, but it is also absolutely necessary in order to give effective care to patients.
  • Yet the FDA published multiple statements and sent letters to influential organizations to falsely disparage ivermectin, implying that it was not approved for treating Covid-19.
  • The FDA insisted and continues to insist on interfering with the prescription of this safe medication by physicians in treating Covid-19, AAPS added.
  • The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties since 1943.

First Trial Date Set for Exactech Hip Knee and Ankle Cases Consolidated in Florida Court

Retrieved on: 
Sunday, September 18, 2022
Knee, Efficiency, Department, Justice, Review, Court, Polyethylene, Patient, Human services, Eighth, Sissel v. United States Department of Health & Human Services, Consolidation, Ankle, Lawyer, Case management, Health, Tobacco, Practice of law

SARASOTA, Fla., Sept. 18, 2022 /PRNewswire-PRWeb/ -- Justice is moving swiftly for plaintiffs in the Exactech hip, knee, and ankle litigation. The first trial date is set for November 6th, a little more than a year from now. Mctlaw attorney, Ilyas Sayeg won arguments to move all FL Exactech lawsuits into a consolidated master case in the Eighth Judicial Circuit of Florida (Case No. 01-2022-CA-2670). Further, the Alachua Circuit Court agrees to consolidate all Exactech lawsuits under the management of Hon. Donna Keim.

Key Points: 
  • The first trial date is set for Exactech hip, knee, and ankle lawsuits in the Eighth Judicial Circuit of Florida (Case No.
  • Mctlaw attorney, Ilyas Sayeg, won arguments to move all FL Exactech lawsuits into a consolidated master case in the district.
  • The Court in Alachua County, Florida is the ideal venue to file these cases since Exactech is a Gainesville, FL-based company.
  • SARASOTA, Fla., Sept. 18, 2022 /PRNewswire-PRWeb/ -- Justice is moving swiftly for plaintiffs in the Exactech hip, knee, and ankle litigation.

United States Medical Coding Market Analysis Report 2022: A $32.6 Billion Market by 2030 - Increasing Automation and Development of New Technologies for Faster and More Efficient Medical Coding - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 6, 2022
Managed Care, Health Technology, Health, Health care, COVID-19, Psychiatry, Centers for Medicare & Medicaid Services, American Health Information Management Association, Telehealth, Solution, USD, California Health and Human Services Agency, Health, Department, Health information management, Rancho Los Amigos National Rehabilitation Center, Sissel v. United States Department of Health & Human Services, Optum, HCPCS, Hospital, Center, Component, CPT, Medicare, Compliance, CAGR, Automation, ICD, Adoption, Medical device, Health insurance

Increasing automation and the development of new technologies for faster and more efficient medical coding are positively impacting market growth potential.

Key Points: 
  • Increasing automation and the development of new technologies for faster and more efficient medical coding are positively impacting market growth potential.
  • Healthcare organizations are increasingly adopting computer-assisted coding, and automated medical billing to increase productivity, transparency, accuracy, compliance, and traceability.
  • For instance, according to the American Health Information Management Association, computer-assisted coding results in an increase in the productivity of coders by 20%.
  • Additionally, factors such as the rapid digitalization of healthcare and the adoption of electronic health records, telemedicine, and other patient management software are positively impacting the medical coding market.

Worldwide Vaccine Contract Manufacturing Industry to 2027 - Increase in Initiatives Favouring Vaccinations is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 25, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, COVID-19, Infectious Diseases, COVID-19, Human services, Safety, Membrane protein, Research, Awareness, Vaccine, Disease, Hepatitis, Scientific Reports, Health, Sissel v. United States Department of Health & Human Services, Hepatitis B, Infection, Capsid, Severe acute respiratory syndrome coronavirus 2, Multi, Population, SARS, Growth, Envelope, Adoption

These advantages are expected to propel the growth of the inactivated vaccine segment in the vaccine contract manufacturing market in the forecast period.

Key Points: 
  • These advantages are expected to propel the growth of the inactivated vaccine segment in the vaccine contract manufacturing market in the forecast period.
  • These advantages of inactivated vaccines and the growing research on the vaccine production during the COVID-19 is adding to the growth of the vaccine contract manufacturing market.
  • The rising number of COVID-19 cases in the North American region is adding to the growth of the vaccine contract manufacturing market.
  • The large population affected by the SARS-CoV2 infection and the increase in the necessity of vaccine contract manufacturing for the ease of treatment of such infections is expected to propel the growth of the vaccine contract manufacturing market.

Winston & Strawn Brings Amy Kearbey to D.C. Health Care and Life Sciences Team

Retrieved on: 
Thursday, July 14, 2022
Sissel v. United States Department of Health & Human Services, Compliance, Health, Leadership, International law, False Claims Act, Winston & Strawn, The Inspector General, Civil, Justice, Human services, Anti-Kickback Statute, Fraud, Office of Inspector General (United States), Policy, Laboratory, Stark Law, United States Department of Justice, Hospital, HHS, Pharmaceutical industry

WASHINGTON, July 14, 2022 /PRNewswire/ -- Winston & Strawn LLP announced today the addition of Amy H. Kearbey as a partner in the Washington, D.C., office.

Key Points: 
  • WASHINGTON, July 14, 2022 /PRNewswire/ -- Winston & Strawn LLP announced today the addition of Amy H. Kearbey as a partner in the Washington, D.C., office.
  • Amy joins the firm as a member of the Litigation Department with a focus in health care and life sciences.
  • "I am pleased to join a firm with the resources, insight, and experience that the health care sector demands," said Amy.
  • "Litigation in the health care sector continues to accelerate post-pandemic," said Winston Chairman Tom Fitzgerald.

NEW VIDEO GAME COMPANY DEEPWELL DTx UNITES GAMES VETS & MEDICAL EXPERTS TO HARNESS THE THERAPEUTIC POWER OF INTERACTIVE ENTERTAINMENT

Retrieved on: 
Tuesday, March 15, 2022
HHS, Sissel v. United States Department of Health & Human Services, Devolver Digital, American, World, Patient, Treatment, WHO, Public health, Therapy, Katy Deepwell, FDA, Lists of diseases, COVID-19, Disability, LON, Neonatal Behavioral Assessment Scale, Video game, Video, Single-frequency network, Depression, World Health Organization, Systematic review, Medication, Medicine, Anxiety, Mental health, Founder, Health, Medtech, Etal, Research, CEO, Wilson, Journal of Psychopathology and Behavioral Assessment, American McGee, Human services, Advisory board, Brabantsche Compagnie, The Advisory Board Company, Video game console, Pharmaceutical industry, Hospital, Psychopathology

SEATTLE, March 15, 2022 /PRNewswire/ -- Revealed today after months of development, research, and recruiting, DeepWell Digital Therapeutics (DTx) is a first-of-its-kind video game publisher and developer dedicated to creating best-in-class gameplay that can simultaneously entertain and deliver, enhance, and accelerate treatment for an array of globally pervasive health conditions.

Key Points: 
  • DeepWell is the creation of Devolver Digital (LON:DEVO) Co-Founder Mike Wilson and Ryan Douglas, the Founder and former CEO of international medical device company Nextern.
  • DeepWell isalready hard at work on a slate of DTx-enabled games that will support the company's patented technical processes and systems.
  • "But the scientists who study video games, as well as the developers that build them at the highest levels, already know that the opposite is true1.
  • DeepWell is a video game developer and publisher dedicated to making games that are simultaneously world-class entertainment, as well as therapeutic for a myriad of health concerns.